Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor modulation of inflammatory response in human endotoxemia
2014-005537-30Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor in endotoxemia, sponsored by Radboud University Medical Center. Primary endpoint: TNF-alpha area under the curve. Started Jan 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
endotoxemia
Beyond the preview
Go deeper on 2014-005537-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005537-30.